Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman*, Jeffery Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D'Angelo, Kent C. Shih, Céleste Lebbé, Gerald P. Linette, Michele Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Kevin Chin, Lisa Mahnke, Anja von Heydebreck, Jean Marie Cuillerot, Paul Nghiem

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

806 Scopus citations

Fingerprint

Dive into the research topics of 'Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences